Aurobindo Pharma Limited
NDC Database
Aurobindo Pharma Limited
NDC Database
National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.
- Total Records 869
- Latest Marketing Date 2026-06-17
- Data Source FDA
- First Marketing Date 2004-10-22
Company Overview
Social Profiles
Company Snapshot
Aurobindo Pharma Limited
Plot no. 2, Maitrivihar, Ameerpet, Hyderabad - 500038 Andhra Pradesh
India
www.aurobindo.com/ info@aurobindo.com View on MapNDC Records ( 869 records )
Nonproprietary Name
Omeprazole
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OMEPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Omeprazole
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OMEPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Omeprazole
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OMEPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Octreotide Acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OCTREOTIDE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2015-09-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine (Form-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OLANZAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ranolazine
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RANOLAZINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-12-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ranolazine
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
1000 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RANOLAZINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-12-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Linaclotide
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LINACLOTIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2015-11-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirabegron
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MIRABEGRON
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lorcaserin Hydrochloride Hemihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LORCASERIN HYDROCHLORIDE HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Loperamide Hydrochloride
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LOPERAMIDE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-07-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-07-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Desmopressin Acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DESMOPRESSIN ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
60; 120 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-10-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen
Dosage Form
TABLET, EXTENDED RELEASE
Strength
650 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-11-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Loratadine
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LORATADINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-04-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Teriflunomide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TERIFLUNOMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dofetilide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DOFETILIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM DIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-03-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Omeprazole
Dosage Form
TABLET, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OMEPRAZOLE MAGNESIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Apixaban
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
APIXABAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famotidine
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMOTIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-04-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ezetimibe
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EZETIMIBE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dimethyl Fumarate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DIMETHYL FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Canagliflozin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CANAGLIFLOZIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin and Dextromethorphan HBr
Dosage Form
TABLET, EXTENDED RELEASE
Strength
30; 600 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-03-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin and Dextromethorphan HBr
Dosage Form
TABLET, EXTENDED RELEASE
Strength
60; 1200 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-03-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Loratadine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LORATADINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-04-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sevelamer Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SEVELAMER HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Colesevelam Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
COLESEVELAM HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Leuprolide Acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LEUPROLIDE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2016-11-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atovaquone
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ATOVAQUONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dronedarone Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DRONEDARONE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMOXICILLIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Silodosin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SILODOSIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Eletriptan Hydrobromide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ELETRIPTAN HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Darunavir Propylene Glycolate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DARUNAVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Febuxostat
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FEBUXOSTAT
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin
Dosage Form
TABLET, EXTENDED RELEASE
Strength
600 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GUAIFENESIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-10-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin
Dosage Form
TABLET, EXTENDED RELEASE
Strength
1200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GUAIFENESIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-10-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ganciclovir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GANCICLOVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosaprepitant Dimeglumine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FOSAPREPITANT DIMEGLUMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famotidine
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMOTIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-04-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Diphenhydramine HCl and Ibuprofen
Dosage Form
CAPSULE, LIQUID FILLED
Strength
25; 200 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-02-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Macitentan
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MACITENTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Flecainide Acetate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FLECAINIDE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dapagliflozin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DAPAGLIFLOZIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Isoproterenol Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ISOPROTERENOL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Hydralazine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
HYDRALAZINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Loperamide Hydrochloride and Simethicone
Dosage Form
TABLET
Strength
125; 2 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DIMETHICONE; LOPERAMIDE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-12-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Apremilast
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
APREMILAST
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sumatriptan Succinate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SUMATRIPTAN SUCCINATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
acetaminophen, aspirin and caffeine
Dosage Form
TABLET, FILM COATED
Strength
250; 250; 65 mg/1; mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; ASPIRIN; CAFFEINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-02-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carmustine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CARMUSTINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sodium Nitroprusside
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SODIUM NITROPRUSSIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Empagliflozin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EMPAGLIFLOZIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Loratadine
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LORATADINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ertapenem Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ERTAPENEM SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
TABLET, FILM COATED
Strength
220 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-12-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pirfenidone
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PIRFENIDONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Roflumilast
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ROFLUMILAST
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dichlorphenamide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DICHLORPHENAMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephalexin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEPHALEXIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sitagliptin Phosphate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SITAGLIPTIN PHOSPHATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Teriparatide
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TERIPARATIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Vasopressin
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VASOPRESSIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2018-08-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Neostigmine Methylsulfate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NEOSTIGMINE METHYLSULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Penicillamine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PENICILLAMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-12-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glipizide
Dosage Form
TABLET, EXTENDED RELEASE
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIPIZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glipizide
Dosage Form
TABLET, EXTENDED RELEASE
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIPIZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glipizide
Dosage Form
TABLET, EXTENDED RELEASE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIPIZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naloxegol Oxalate Premix
Dosage Form
POWDER
Strength
25 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
NALOXEGOL OXALATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Duloxetine Hydrochloride
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DULOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-12-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Duloxetine Hydrochloride
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DULOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-12-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Duloxetine Hydrochloride
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DULOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-12-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin and Pseudoephedrine HCl
Dosage Form
TABLET, EXTENDED RELEASE
Strength
600; 60 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Guaifenesin and Pseudoephedrine HCl
Dosage Form
TABLET, EXTENDED RELEASE
Strength
1200; 120 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ZAFIRLUKAST
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZAFIRLUKAST
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ZAFIRLUKAST
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZAFIRLUKAST
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Phenoxybenzamine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PHENOXYBENZAMINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CHLORZOXAZONE
Dosage Form
TABLET
Strength
375 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CHLORZOXAZONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CHLORZOXAZONE
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CHLORZOXAZONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-08-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CHLORZOXAZONE
Dosage Form
TABLET
Strength
750 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CHLORZOXAZONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-04-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-04-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Omeprazole
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OMEPRAZOLE MAGNESIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-04-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tizanidine Hydrochloride
Dosage Form
CAPSULE
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TIZANIDINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tizanidine Hydrochloride
Dosage Form
CAPSULE
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TIZANIDINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tizanidine Hydrochloride
Dosage Form
CAPSULE
Strength
6 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TIZANIDINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-03-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
TABLET, FILM COATED
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-06-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PHENOXYBENZAMINE HYDROCHLORIDE
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PHENOXYBENZAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-05-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Brexpiprazole
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BREXPIPRAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Eluxadoline
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ELUXADOLINE
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FLUCYTOSINE
Dosage Form
CAPSULE
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUCYTOSINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FLUCYTOSINE
Dosage Form
CAPSULE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUCYTOSINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sacubitril-Valsartan Premix
Dosage Form
POWDER
Strength
43 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
SACUBITRIL VALSARTAN SODIUM HYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-07-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Duloxetine Hydrochloride (Process II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DULOXETINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
DICLOFENAC POTASSIUM
Dosage Form
CAPSULE, LIQUID FILLED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DICLOFENAC POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
400 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
600 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
800 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-05-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Icatibant Acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ICATIBANT ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2020-12-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Vigabatrin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VIGABATRIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tipiracil Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TIPIRACIL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole (Process II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ARIPIPRAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ZONISAMIDE
Dosage Form
CAPSULE
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZONISAMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-08-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ZONISAMIDE
Dosage Form
CAPSULE
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZONISAMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-08-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ZONISAMIDE
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZONISAMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-08-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
CLOMIPRAMINE HYDROCHLORIDE
Dosage Form
CAPSULE
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOMIPRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLOMIPRAMINE HYDROCHLORIDE
Dosage Form
CAPSULE
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOMIPRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLOMIPRAMINE HYDROCHLORIDE
Dosage Form
CAPSULE
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOMIPRAMINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trifluridine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TRIFLURIDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
BACLOFEN
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BACLOFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-07-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
BACLOFEN
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BACLOFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-07-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mesalamine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MESALAMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clopidogrel Bisulfate (Form II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CLOPIDOGREL BISULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine Hydrochloride Process II
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cariprazine Hydrochloride Premix
Dosage Form
POWDER
Strength
25 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
CARIPRAZINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Erythromycin Lactobionate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ERYTHROMYCIN LACTOBIONATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sugammadex Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SUGAMMADEX SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Deferasirox
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DEFERASIROX
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ursodiol
Dosage Form
CAPSULE
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
URSODIOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-11-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cevimeline Hydrochloride
Dosage Form
CAPSULE
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEVIMELINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-04-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium
Dosage Form
TABLET, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM DIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-07-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tramadol Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRAMADOL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2020-09-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lifitegrast
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LIFITEGRAST
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
COLCHICINE
Dosage Form
CAPSULE
Strength
0.6 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
COLCHICINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
180; 240 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-04-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Colchicine
Dosage Form
TABLET
Strength
0.6 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
COLCHICINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dasatinib
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DASATINIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ramelteon
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RAMELTEON
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ceftiofur Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFTIOFUR SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paliperidone
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PALIPERIDONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Foscarnet Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FOSCARNET SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Degarelix
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DEGARELIX
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2020-08-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Eslicarbazepine Acetate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ESLICARBAZEPINE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tenofovir Alafenamide Fumarate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TENOFOVIR ALAFENAMIDE FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Docosanol
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DOCOSANOL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Safinamide Mesylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SAFINAMIDE MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Deutetrabenazine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DEUTETRABENAZINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Azilsartan Kamedoxomil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AZILSARTAN KAMEDOXOMIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Hydroxyzine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROXYZINE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-10-07
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Hydroxyzine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROXYZINE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-10-07
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Hydroxyzine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROXYZINE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-10-07
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Etelcalcetide Hydrochloride
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ETELCALCETIDE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2020-11-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glatiramer Acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GLATIRAMER ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2020-12-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, EXTENDED RELEASE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-04-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, EXTENDED RELEASE
Strength
750 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-04-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Calcitonin Salmon
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CALCITONIN SALMON
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2021-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ESOMEPRAZOLE MAGNESIUM
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ESOMEPRAZOLE MAGNESIUM
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-11-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pyrimethamine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PYRIMETHAMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ivacaftor
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
IVACAFTOR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ganirelix Acetate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GANIRELIX ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2021-07-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ertugliflozin L-Pyroglutamic Acid
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ERTUGLIFLOZIN L-PYROGLUTAMIC ACID
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ivacaftor Premix
Dosage Form
POWDER
Strength
38 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
IVACAFTOR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paclitaxel
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PACLITAXEL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ATORVASTATIN CALCIUM
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATORVASTATIN CALCIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-02-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ATORVASTATIN CALCIUM
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATORVASTATIN CALCIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-02-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ATORVASTATIN CALCIUM
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATORVASTATIN CALCIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-02-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
ATORVASTATIN CALCIUM
Dosage Form
TABLET, FILM COATED
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATORVASTATIN CALCIUM TRIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-02-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Imatinib Mesylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
IMATINIB MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Apalutamide Premix
Dosage Form
POWDER
Strength
12.5 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
APALUTAMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tezacaftor Premix
Dosage Form
POWDER
Strength
40 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
TEZACAFTOR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Plecanatide
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PLECANATIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2021-09-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Eltrombopag Olamine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ELTROMBOPAG OLAMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-04-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-08-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Baricitinib
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BARICITINIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
IBUPROFEN AND PSEUDOEPHEDRINE HCL
Dosage Form
CAPSULE, LIQUID FILLED
Strength
200; 30 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-04-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Encorafenib
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ENCORAFENIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sorafenib Tosylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SORAFENIB TOSYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Oxybutynin Chloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OXYBUTYNIN CHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famotidine
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMOTIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-07-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ACETAMINOPHEN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-12-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Migalastat Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MIGALASTAT HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-03-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Revefenacin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
REVEFENACIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Melphalan Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MELPHALAN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FLUPHENAZINE HYDROCHLORIDE
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUPHENAZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FLUPHENAZINE HYDROCHLORIDE
Dosage Form
TABLET
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUPHENAZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FLUPHENAZINE HYDROCHLORIDE
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUPHENAZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FLUPHENAZINE HYDROCHLORIDE
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUPHENAZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen and Diphenhydramine Citrate
Dosage Form
TABLET, COATED
Strength
38; 200 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DIPHENHYDRAMINE CITRATE; IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-05-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ezetimibe
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EZETIMIBE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Diphenhydramine HCl and Ibuprofen
Dosage Form
CAPSULE, LIQUID FILLED
Strength
25; 200 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-08-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
TRAZODONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRAZODONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
TRAZODONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRAZODONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
TRAZODONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRAZODONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
TRAZODONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRAZODONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Abiraterone Acetate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ABIRATERONE ACETATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tafamidis Meglumine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TAFAMIDIS MEGLUMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trametinib Acetic Acid
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TRAMETINIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLORAZEPATE DIPOTASSIUM
Dosage Form
TABLET
Strength
3.75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLORAZEPATE DIPOTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2023-09-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLORAZEPATE DIPOTASSIUM
Dosage Form
TABLET
Strength
7.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLORAZEPATE DIPOTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2023-09-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLORAZEPATE DIPOTASSIUM
Dosage Form
TABLET
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLORAZEPATE DIPOTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2023-09-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLONAZEPAM
Dosage Form
TABLET
Strength
0.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLONAZEPAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2023-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLONAZEPAM
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLONAZEPAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2023-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLONAZEPAM
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLONAZEPAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2023-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephalexin
Dosage Form
CAPSULE
Strength
750 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEPHALEXIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen and Ibuprofen
Dosage Form
TABLET, FILM COATED
Strength
250; 125 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-03-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lenalidomide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LENALIDOMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Siponimod Fumaric Acid
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SIPONIMOD HEMIFUMARIC ACID
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dexrazoxane
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DEXRAZOXANE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
GLYCOPYRROLATE
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLYCOPYRROLATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-02-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
GLYCOPYRROLATE
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLYCOPYRROLATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-02-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tafamidis
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TAFAMIDIS
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Acetaminophen and Ibuprofen
Dosage Form
TABLET, FILM COATED
Strength
250; 125 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN; IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-03-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate Process-II
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
QUETIAPINE FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Solriamfetol Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SOLRIAMFETOL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2023-11-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dextromethorphan Polistirex
Dosage Form
POWDER
Strength
20 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
DEXTROMETHORPHAN HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ampicillin Trihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMPICILLIN TRIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Liraglutide
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LIRAGLUTIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glipizide
Dosage Form
TABLET, EXTENDED RELEASE
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIPIZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-03
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Glipizide
Dosage Form
TABLET, EXTENDED RELEASE
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIPIZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-03
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Glipizide
Dosage Form
TABLET, EXTENDED RELEASE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIPIZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-03
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Upadacitinib
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
UPADACITINIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FUROSEMIDE
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FUROSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FUROSEMIDE
Dosage Form
TABLET
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FUROSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
FUROSEMIDE
Dosage Form
TABLET
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FUROSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CIMETIDINE
Dosage Form
TABLET, FILM COATED
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIMETIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-11-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CIMETIDINE
Dosage Form
TABLET, FILM COATED
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIMETIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-11-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CIMETIDINE
Dosage Form
TABLET, FILM COATED
Strength
400 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIMETIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-11-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CIMETIDINE
Dosage Form
TABLET, FILM COATED
Strength
800 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIMETIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-11-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
850 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
1000 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famotidine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FAMOTIDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aztreoanm
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AZTREONAM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ubrogepant
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
UBROGEPANT
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Azacitidine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AZACITIDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
POLYETHYLENE GLYCOL 3350
Dosage Form
POWDER, FOR SOLUTION
Strength
17 g/17g
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
POLYETHYLENE GLYCOL 3350
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ziprasidone Mesylate Trihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZIPRASIDONE MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paliperidone Palmitate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PALIPERIDONE PALMITATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Bempedoic Acid
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BEMPEDOIC ACID
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cenobamate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CENOBAMATE
Product Type
BULK INGREDIENT
DEA Schedule
CV
Start Marketing Date
2023-11-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin Enacarbil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GABAPENTIN ENACARBIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMOXICILLIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rimegepant Sulfate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIMEGEPANT SULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
IBUPROFEN
Dosage Form
CAPSULE, LIQUID FILLED
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-09-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
CAPSULE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
CAPSULE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-07-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Raltegravir Potassium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RALTEGRAVIR POTASSIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephapirin Benzathine Process-II
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEPHAPIRIN BENZATHINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Triheptanoin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TRIHEPTANOIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sulbactam Sodium Sterile Process-II
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SULBACTAM SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-02-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Abacavir Sulfate (Process II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ABACAVIR SULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-02-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefdinir (Anhydrous)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFDINIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-02-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pantoprazole Sodium Process-II
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PANTOPRAZOLE SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-04-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lacosamide (CIP Process)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LACOSAMIDE
Product Type
BULK INGREDIENT
DEA Schedule
CV
Start Marketing Date
2024-04-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefpodoxime Proxetil (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFPODOXIME PROXETIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluconazole (CIP Process)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FLUCONAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-04-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ciprofloxacin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ciprofloxacin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ciprofloxacin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
750 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glycerol Phenylbutyrate
Dosage Form
LIQUID
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GLYCEROL PHENYLBUTYRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-08-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
6-Aminopenicillanic Acid
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
6-AMINOPENICILLANIC ACID
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-08-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
LOPERAMIDE HYDROCHLORIDE
Dosage Form
CAPSULE, LIQUID FILLED
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LOPERAMIDE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-12-29
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, FILM COATED
Strength
7.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, FILM COATED
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Citalopram Hydrobromide
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CITALOPRAM HYDROBROMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Citalopram Hydrobromide
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CITALOPRAM HYDROBROMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Citalopram Hydrobromide
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CITALOPRAM HYDROBROMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-01-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
850 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-01-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
1000 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-01-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SERTRALINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-02-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SERTRALINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-02-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SERTRALINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-02-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-11-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin
Dosage Form
TABLET, FILM COATED
Strength
875 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-11-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin
Dosage Form
CAPSULE
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-09-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin
Dosage Form
CAPSULE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-09-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephalexin
Dosage Form
CAPSULE
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEPHALEXIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-11-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephalexin
Dosage Form
CAPSULE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEPHALEXIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-11-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
45 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zidovudine
Dosage Form
TABLET, FILM COATED
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZIDOVUDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2005-09-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamivudine
Dosage Form
TABLET, FILM COATED
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMIVUDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-11-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamivudine
Dosage Form
TABLET, FILM COATED
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMIVUDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-11-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Nevirapine
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NEVIRAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-05-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, FILM COATED
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine
Dosage Form
TABLET, FILM COATED
Strength
45 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MIRTAZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2004-10-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamivudine and Zidovudine
Dosage Form
TABLET, FILM COATED
Strength
150; 300 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMIVUDINE; ZIDOVUDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril
Dosage Form
TABLET
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril
Dosage Form
TABLET
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril
Dosage Form
TABLET
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril and Hydrochlorothiazide
Dosage Form
TABLET
Strength
12.5; 10 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril and Hydrochlorothiazide
Dosage Form
TABLET
Strength
12.5; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lisinopril and Hydrochlorothiazide
Dosage Form
TABLET
Strength
25; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; LISINOPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Efavirenz
Dosage Form
TABLET, FILM COATED
Strength
600 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EFAVIRENZ
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Simvastatin
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SIMVASTATIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Simvastatin
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SIMVASTATIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Simvastatin
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SIMVASTATIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Simvastatin
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SIMVASTATIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Simvastatin
Dosage Form
TABLET, FILM COATED
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SIMVASTATIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluconazole
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUCONAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-10-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluconazole
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUCONAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-10-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluconazole
Dosage Form
TABLET
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUCONAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-10-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluconazole
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUCONAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-10-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metoprolol Tartrate
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METOPROLOL TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metoprolol Tartrate
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METOPROLOL TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metoprolol Tartrate
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METOPROLOL TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefprozil
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFPROZIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-05-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefprozil
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFPROZIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-05-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Abacavir
Dosage Form
TABLET, FILM COATED
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ABACAVIR SULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-12-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Terbinafine Hydrochloride
Dosage Form
TABLET
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TERBINAFINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glyburide and Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
1.25; 250 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLYBURIDE; METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glyburide and Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
2.5; 500 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLYBURIDE; METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glyburide and Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
5; 500 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLYBURIDE; METFORMIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefadroxil
Dosage Form
CAPSULE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFADROXIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-01-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Bisoprolol Fumarate
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BISOPROLOL FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Bisoprolol Fumarate
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BISOPROLOL FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-12-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CEFPODOXIME PROXETIL
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFPODOXIME PROXETIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-06-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CEFPODOXIME PROXETIL
Dosage Form
TABLET, FILM COATED
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFPODOXIME PROXETIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-06-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Meloxicam
Dosage Form
TABLET
Strength
7.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MELOXICAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-10-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Meloxicam
Dosage Form
TABLET
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MELOXICAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-10-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine Besylate
Dosage Form
TABLET
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Amlodipine Besylate
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Amlodipine Besylate
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Efavirenz
Dosage Form
CAPSULE
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EFAVIRENZ
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Efavirenz
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EFAVIRENZ
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Efavirenz
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EFAVIRENZ
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zidovudine
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZIDOVUDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Hydrochlorothiazide
Dosage Form
CAPSULE
Strength
12.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Benazepril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-05-22
End Marketing Date
2026-11-30
Listing Record Certified Through
-
Nonproprietary Name
Benazepril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-05-22
End Marketing Date
2026-11-30
Listing Record Certified Through
-
Nonproprietary Name
Torsemide
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TORSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Torsemide
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TORSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Torsemide
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TORSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Torsemide
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TORSEMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Hydrochlorothiazide
Dosage Form
TABLET
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Hydrochlorothiazide
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carvedilol
Dosage Form
TABLET, FILM COATED
Strength
3.125 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CARVEDILOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carvedilol
Dosage Form
TABLET, FILM COATED
Strength
6.25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CARVEDILOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carvedilol
Dosage Form
TABLET, FILM COATED
Strength
12.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CARVEDILOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carvedilol
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CARVEDILOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sumatriptan Succinate
Dosage Form
TABLET
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SUMATRIPTAN SUCCINATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sumatriptan Succinate
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SUMATRIPTAN SUCCINATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sumatriptan Succinate
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SUMATRIPTAN SUCCINATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-08-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Finasteride
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FINASTERIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paroxetine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paroxetine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paroxetine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paroxetine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
carisoprodol
Dosage Form
TABLET
Strength
350 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CARISOPRODOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2009-08-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zolpidem Tartrate
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZOLPIDEM TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2007-05-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zolpidem Tartrate
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZOLPIDEM TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2007-05-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride/Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 10 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-08-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride/Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-08-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride/Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
25; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-08-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trandolapril
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRANDOLAPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-06-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trandolapril
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRANDOLAPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-06-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trandolapril
Dosage Form
TABLET
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TRANDOLAPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-06-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atenolol
Dosage Form
TABLET
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATENOLOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atenolol
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATENOLOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atenolol
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATENOLOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-10-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Topiramate
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TOPIRAMATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Topiramate
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TOPIRAMATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Topiramate
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TOPIRAMATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Topiramate
Dosage Form
TABLET, FILM COATED
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TOPIRAMATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Penicillin V Potassium
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PENICILLIN V POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Penicillin V Potassium
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PENICILLIN V POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
cefdinir
Dosage Form
CAPSULE
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFDINIR
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clindamycin Hydrochloride
Dosage Form
CAPSULE
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLINDAMYCIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-08-26
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Clindamycin Hydrochloride
Dosage Form
CAPSULE
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLINDAMYCIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-08-26
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Ondansetron Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ONDANSETRON HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ondansetron Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
8 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ONDANSETRON HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ondansetron Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
24 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ONDANSETRON HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2007-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cyclobenzaprine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CYCLOBENZAPRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-09-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cyclobenzaprine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CYCLOBENZAPRINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-09-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine Hydrochloride
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine Hydrochloride
Dosage Form
CAPSULE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine Hydrochloride
Dosage Form
CAPSULE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zaleplon
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZALEPLON
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GABAPENTIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin
Dosage Form
CAPSULE
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GABAPENTIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin
Dosage Form
CAPSULE
Strength
400 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GABAPENTIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-01-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Doxazosin Mesylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DOXAZOSIN MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Terazosin Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TERAZOSIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alfuzosin Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ALFUZOSIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ribavirin
Dosage Form
TABLET, FILM COATED
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIBAVIRIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-09-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
CAPSULE
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
CAPSULE
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephapirin Benzathine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEPHAPIRIN BENZATHINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ZALEPLON
Dosage Form
CAPSULE
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZALEPLON
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2008-06-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ZALEPLON
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZALEPLON
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2008-06-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metformin Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
METFORMIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Simvastatin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SIMVASTATIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SERTRALINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Meloxicam
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MELOXICAM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clarithromycin
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLARITHROMYCIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-07-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clarithromycin
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLARITHROMYCIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-07-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamotrigine
Dosage Form
TABLET
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMOTRIGINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamotrigine
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMOTRIGINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamotrigine
Dosage Form
TABLET
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMOTRIGINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamotrigine
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LAMOTRIGINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibandronate Sodium
Dosage Form
TABLET, FILM COATED
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBANDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
18 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-05-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levetiracetam
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVETIRACETAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levetiracetam
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVETIRACETAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levetiracetam
Dosage Form
TABLET, FILM COATED
Strength
750 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVETIRACETAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alfuzosin Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALFUZOSIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-08-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Abacavir Sulfate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ABACAVIR SULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Nevirapine Anhydrous
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NEVIRAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zidovudine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZIDOVUDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamivudine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LAMIVUDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carisoprodol
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CARISOPRODOL
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levetiracetam
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LEVETIRACETAM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
QUETIAPINE FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Stavudine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
STAVUDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lopinavir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LOPINAVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamotrigine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LAMOTRIGINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Efavirenz
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EFAVIRENZ
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alendronate Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ALENDRONATE SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atomoxetine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ATOMOXETINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibandronate Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
IBANDRONATE SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMOXICILLIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ampicillin Trihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMPICILLIN TRIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Oxacillin Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OXACILLIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Piperacillin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PIPERACILLIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dicloxacillin Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DICLOXACILLIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sulbactam Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SULBACTAM SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tazobactam Hemihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TAZOBACTAM HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ampicillin Sodium (Sterile)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMPICILLIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ampicillin and Sulbactam for Injection
Dosage Form
POWDER
Strength
33.25; 16.75 kg/50kg; kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
AMPICILLIN SODIUM; SULBACTAM SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sulbactam Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SULBACTAM SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Perindopril Erbumine
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PERINDOPRIL ERBUMINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-11-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Perindopril Erbumine
Dosage Form
TABLET
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PERINDOPRIL ERBUMINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-11-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Perindopril Erbumine
Dosage Form
TABLET
Strength
8 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PERINDOPRIL ERBUMINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-11-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ribavirin
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIBAVIRIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-09-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rosuvastatin Calcium
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ROSUVASTATIN CALCIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-07-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rosuvastatin Calcium
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ROSUVASTATIN CALCIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-07-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rosuvastatin Calcium
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ROSUVASTATIN CALCIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-07-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rosuvastatin Calcium
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ROSUVASTATIN CALCIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-07-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluconazole
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FLUCONAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tamsulosin Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TAMSULOSIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Emtricitabine
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EMTRICITABINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rosuvastatin Calcium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ROSUVASTATIN CALCIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Emtricitabine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EMTRICITABINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosinopril Sodium and Hydrochlorothiazide
Dosage Form
TABLET
Strength
10; 12.5 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-07-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosinopril Sodium and Hydrochlorothiazide
Dosage Form
TABLET
Strength
20; 12.5 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-07-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ceftiofur Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFTIOFUR HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levetiracetam
Dosage Form
TABLET, FILM COATED
Strength
1000 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVETIRACETAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2009-01-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine Anhydrous
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MIRTAZAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glyburide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GLYBURIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ramipril
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RAMIPRIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zidovudine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZIDOVUDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Didanosine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DIDANOSINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Hydrochlorothiazide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
HYDROCHLOROTHIAZIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Efavirenz
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EFAVIRENZ
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Donepezil Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DONEPEZIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-05-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Donepezil Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DONEPEZIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-05-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alendronate Sodium
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALENDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-08-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alendronate Sodium
Dosage Form
TABLET
Strength
35 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALENDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-08-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alendronate Sodium
Dosage Form
TABLET
Strength
70 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALENDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2008-08-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
abacavir and lamivudine
Dosage Form
TABLET, FILM COATED
Strength
600; 300 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ABACAVIR SULFATE; LAMIVUDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Citalopram Hydrobromide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CITALOPRAM HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cephalexin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEPHALEXIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefuroxime Axetil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFUROXIME AXETIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Nevirapine Anhydrous
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NEVIRAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Stavudine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
STAVUDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine Besylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMLODIPINE BESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zolpidem Tartrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZOLPIDEM TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2023-12-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Benazepril Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BENAZEPRIL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fluoxetine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Emtricitabine and Tenofovir Disoproxil Fumarate
Dosage Form
TABLET, FILM COATED
Strength
200; 300 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-03-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clopidogrel Bisulfate
Dosage Form
TABLET, FILM COATED
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOPIDOGREL BISULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-05-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefadroxil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFADROXIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Terbinafine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TERBINAFINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Risperidone
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RISPERIDONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Nevirapine Hemihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NEVIRAPINE HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
QUINAPRIL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Carvedilol
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CARVEDILOL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Finasteride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FINASTERIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sumatriptan Succinate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SUMATRIPTAN SUCCINATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clopidogrel Bisulfate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CLOPIDOGREL BISULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ondansetron Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ONDANSETRON HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefprozil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFPROZIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ciprofloxacin Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CIPROFLOXACIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Bisoprolol Fumarate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BISOPROLOL FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefpodoxime Proxetil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFPODOXIME PROXETIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Paroxetine Hydrochloride (Hemihydrate)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PAROXETINE HYDROCHLORIDE HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Topiramate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TOPIRAMATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefdinir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFDINIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GABAPENTIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Trandolapril
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TRANDOLAPRIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosinopril Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FOSINOPRIL SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tolterodine Tartrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TOLTERODINE TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Omeprazole
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OMEPRAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Risedronate Sodium Hemipentahydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RISEDRONATE SODIUM HEMI-PENTAHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tenofovir Disoproxil Fumarate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TENOFOVIR DISOPROXIL FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ziprasidone Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZIPRASIDONE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Felodipine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FELODIPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Didanosine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DIDANOSINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ribavirin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIBAVIRIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ritonavir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RITONAVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Escitalopram Oxalate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ESCITALOPRAM OXALATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Bupropion Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BUPROPION HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rabeprazole Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RABEPRAZOLE SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metoprolol Succinate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
METOPROLOL SUCCINATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Metoprolol Tartrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
METOPROLOL TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sulfamethoxazole and Trimethoprim
Dosage Form
TABLET
Strength
400; 80 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SULFAMETHOXAZOLE; TRIMETHOPRIM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-02-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sulfamethoxazole and Trimethoprim
Dosage Form
TABLET
Strength
800; 160 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SULFAMETHOXAZOLE; TRIMETHOPRIM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-02-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tenofovir Disoproxil Fumarate
Dosage Form
TABLET, FILM COATED
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TENOFOVIR DISOPROXIL FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-01-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gemfibrozil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GEMFIBROZIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Perindopril tert-Butylamine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PERINDOPRIL ERBUMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pantoprazole Sodium Sesquihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PANTOPRAZOLE SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LOSARTAN POTASSIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Donepezil Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DONEPEZIL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cetirizine Hydrochloride
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CETIRIZINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET, EXTENDED RELEASE
Strength
0.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2011-06-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET, EXTENDED RELEASE
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2011-06-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET, EXTENDED RELEASE
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2011-06-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET, EXTENDED RELEASE
Strength
3 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2011-06-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Galantamine
Dosage Form
TABLET, FILM COATED
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GALANTAMINE HYDROBROMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Galantamine
Dosage Form
TABLET, FILM COATED
Strength
8 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GALANTAMINE HYDROBROMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Galantamine
Dosage Form
TABLET, FILM COATED
Strength
12 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GALANTAMINE HYDROBROMIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ampicillin Trihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AMPICILLIN TRIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valacyclovir Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VALACYCLOVIR HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Duloxetine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DULOXETINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famciclovir
Dosage Form
TABLET, FILM COATED
Strength
125 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMCICLOVIR
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famciclovir
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMCICLOVIR
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famciclovir
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMCICLOVIR
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 50 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 100 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Losartan Potassium and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
25; 100 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2010-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosinopril Sodium
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FOSINOPRIL SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosinopril Sodium
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FOSINOPRIL SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fosinopril Sodium
Dosage Form
TABLET
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FOSINOPRIL SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-03-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ramipril
Dosage Form
CAPSULE
Strength
1.25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RAMIPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ramipril
Dosage Form
CAPSULE
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RAMIPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ramipril
Dosage Form
CAPSULE
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RAMIPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ramipril
Dosage Form
CAPSULE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RAMIPRIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ceftiofur Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFTIOFUR HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famciclovir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FAMCICLOVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Galantamine Hydrobromide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GALANTAMINE HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levofloxacin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LEVOFLOXACIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quetiapine Fumarate
Dosage Form
TABLET, FILM COATED
Strength
400 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUETIAPINE FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-03-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Dosage Form
TABLET, FILM COATED
Strength
600; 200; 300 mg/1; mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-03-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Oxacillin for Injection
Dosage Form
POWDER
Strength
49.02 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
OXACILLIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Nafcillin for Injection
Dosage Form
POWDER
Strength
48 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Substance
NAFCILLIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin and Clavulanate Potassium
Dosage Form
TABLET, FILM COATED
Strength
250; 125 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN; CLAVULANATE POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-01-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin and Clavulanate Potassium
Dosage Form
TABLET, FILM COATED
Strength
500; 125 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN; CLAVULANATE POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-01-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amoxicillin and Clavulanate Potassium
Dosage Form
TABLET, FILM COATED
Strength
875; 125 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMOXICILLIN; CLAVULANATE POTASSIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-01-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sertraline Hydrochloride (Form I)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SERTRALINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefuroxime Axetil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFUROXIME AXETIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NAPROXEN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pioglitazone Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PIOGLITAZONE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pioglitazone Hydrochloride
Dosage Form
TABLET
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PIOGLITAZONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pioglitazone Hydrochloride
Dosage Form
TABLET
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PIOGLITAZONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pioglitazone Hydrochloride
Dosage Form
TABLET
Strength
45 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PIOGLITAZONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
TABLET, FILM COATED
Strength
275 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-10-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
TABLET, FILM COATED
Strength
550 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-10-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Risedronate Sodium
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RISEDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-11-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Risedronate Sodium
Dosage Form
TABLET, FILM COATED
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RISEDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-11-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Risedronate Sodium
Dosage Form
TABLET, FILM COATED
Strength
35 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RISEDRONATE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-11-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen
Dosage Form
TABLET
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen
Dosage Form
TABLET
Strength
375 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin
Dosage Form
TABLET, FILM COATED
Strength
600 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GABAPENTIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gabapentin
Dosage Form
TABLET, FILM COATED
Strength
800 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GABAPENTIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pioglitazone Hydrochloride and Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
500; 15 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pioglitazone Hydrochloride and Metformin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
850; 15 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Venlafaxine Hydrochloride
Dosage Form
CAPSULE, EXTENDED RELEASE
Strength
37.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VENLAFAXINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Venlafaxine Hydrochloride
Dosage Form
CAPSULE, EXTENDED RELEASE
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VENLAFAXINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
irbesartan
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
IRBESARTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Omeprazole Magnesium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OMEPRAZOLE MAGNESIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Repaglinide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
REPAGLINIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levofloxacin
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVOFLOXACIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levofloxacin
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVOFLOXACIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Levofloxacin
Dosage Form
TABLET, FILM COATED
Strength
750 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LEVOFLOXACIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-06-20
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Torsemide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TORSEMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clindamycin Palmitate Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OLANZAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 80 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 160 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
25; 160 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 320 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
25; 320 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-03-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
45 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-11-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
65 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
90 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-11-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
115 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-09-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Minocycline Hydrochloride
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
135 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MINOCYCLINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-11-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pantoprazole Sodium
Dosage Form
TABLET, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PANTOPRAZOLE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-28
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Pantoprazole Sodium
Dosage Form
TABLET, DELAYED RELEASE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PANTOPRAZOLE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-28
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET
Strength
7.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-04-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Montelukast Sodium
Dosage Form
TABLET, CHEWABLE
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MONTELUKAST SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-08-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Montelukast Sodium
Dosage Form
TABLET, CHEWABLE
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MONTELUKAST SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-08-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan
Dosage Form
TABLET, FILM COATED
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan
Dosage Form
TABLET, FILM COATED
Strength
160 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan
Dosage Form
TABLET, FILM COATED
Strength
320 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VALSARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Montelukast Sodium
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MONTELUKAST SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-08-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Modafinil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MODAFINIL
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2023-11-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lamivudine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LAMIVUDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rizatriptan Benzoate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIZATRIPTAN BENZOATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Glimepiride
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIMEPIRIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-06-29
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Glimepiride
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIMEPIRIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-06-29
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Glimepiride
Dosage Form
TABLET
Strength
4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GLIMEPIRIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-06-29
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Amlodipine and Benazepril Hydrochloride
Dosage Form
CAPSULE
Strength
2.5; 10 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine and Benazepril Hydrochloride
Dosage Form
CAPSULE
Strength
5; 10 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine and Benazepril Hydrochloride
Dosage Form
CAPSULE
Strength
5; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine and Benazepril Hydrochloride
Dosage Form
CAPSULE
Strength
5; 40 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine and Benazepril Hydrochloride
Dosage Form
CAPSULE
Strength
10; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Amlodipine and Benazepril Hydrochloride
Dosage Form
CAPSULE
Strength
10; 40 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Divalproex sodium
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DIVALPROEX SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-06-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Divalproex sodium
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
DIVALPROEX SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-06-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tamsulosin Hydrochloride
Dosage Form
CAPSULE
Strength
0.4 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TAMSULOSIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rizatriptan Benzoate
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIZATRIPTAN BENZOATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-12-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rizatriptan Benzoate
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIZATRIPTAN BENZOATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-12-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Modafinil
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MODAFINIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2012-09-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Modafinil
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MODAFINIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2012-09-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Moxifloxacin Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
400 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MOXIFLOXACIN HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-03-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
TABLET
Strength
0.125 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-10-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
TABLET
Strength
0.25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-10-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
TABLET
Strength
0.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-10-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
TABLET
Strength
0.75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-10-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-10-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pramipexole Dihydrochloride
Dosage Form
TABLET
Strength
1.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAMIPEXOLE DIHYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-10-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Entacapone
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ENTACAPONE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rivastigmine Tartrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIVASTIGMINE TARTRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tramadol Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TRAMADOL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Quinapril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
QUINAPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-04-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Flecainide Acetate
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLECAINIDE ACETATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-07-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Flecainide Acetate
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLECAINIDE ACETATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-07-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Flecainide Acetate
Dosage Form
TABLET
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLECAINIDE ACETATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-07-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gemfibrozil
Dosage Form
TABLET, FILM COATED
Strength
600 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
GEMFIBROZIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-09-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rizatriptan Benzoate
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIZATRIPTAN BENZOATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-07-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rizatriptan Benzoate
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIZATRIPTAN BENZOATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-07-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Moxifloxacin Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MOXIFLOXACIN HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Irbesartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 150 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; IRBESARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Irbesartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 300 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; IRBESARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-02-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Irbesartan and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
25; 300 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; IRBESARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pravastatin sodium
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAVASTATIN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-02
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Pravastatin sodium
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAVASTATIN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-02
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Pravastatin sodium
Dosage Form
TABLET
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAVASTATIN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-02
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Pravastatin sodium
Dosage Form
TABLET
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PRAVASTATIN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-02
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Nevirapine Anhydrous (Process II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NEVIRAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Irbesartan
Dosage Form
TABLET
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IRBESARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Irbesartan
Dosage Form
TABLET
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IRBESARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Irbesartan
Dosage Form
TABLET
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IRBESARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2012-09-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valsartan
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VALSARTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
azithromycin
Dosage Form
TABLET, FILM COATED
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AZITHROMYCIN DIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-09-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
azithromycin
Dosage Form
TABLET, FILM COATED
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
AZITHROMYCIN DIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-09-16
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Rivastigmine Tartrate
Dosage Form
CAPSULE
Strength
1.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIVASTIGMINE TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rivastigmine Tartrate
Dosage Form
CAPSULE
Strength
3 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIVASTIGMINE TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rivastigmine Tartrate
Dosage Form
CAPSULE
Strength
4.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIVASTIGMINE TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rivastigmine Tartrate
Dosage Form
CAPSULE
Strength
6 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RIVASTIGMINE TARTRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Memantine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MEMANTINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Memantine Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MEMANTINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-13
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-05-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-05-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-05-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olanzapine
Dosage Form
TABLET, ORALLY DISINTEGRATING
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLANZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-05-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ARIPIPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ARIPIPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
TABLET
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ARIPIPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
TABLET
Strength
15 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ARIPIPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ARIPIPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
TABLET
Strength
30 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ARIPIPRAZOLE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-10-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Repaglinide
Dosage Form
TABLET
Strength
0.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
REPAGLINIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Repaglinide
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
REPAGLINIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Repaglinide
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
REPAGLINIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Felodipine
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FELODIPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Felodipine
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FELODIPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Felodipine
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FELODIPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2013-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET
Strength
0.25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2015-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET
Strength
0.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2015-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2015-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Alprazolam
Dosage Form
TABLET
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALPRAZOLAM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2015-07-31
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aripiprazole
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ARIPIPRAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
RITONAVIR
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RITONAVIR
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-02-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Phenytoin Sodium
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PHENYTOIN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-06-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
carisoprodol
Dosage Form
TABLET
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CARISOPRODOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2016-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sildenafil Citrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SILDENAFIL CITRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Venlafaxine Hydrochloride
Dosage Form
CAPSULE, EXTENDED RELEASE
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
VENLAFAXINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2011-11-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefuroxime Axetil
Dosage Form
TABLET
Strength
125 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFUROXIME AXETIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefuroxime Axetil
Dosage Form
TABLET
Strength
250 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFUROXIME AXETIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefuroxime Axetil
Dosage Form
TABLET
Strength
500 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CEFUROXIME AXETIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2006-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atazanavir Sulfate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ATAZANAVIR SULFATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ziprasidone Hydrochloride
Dosage Form
CAPSULE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZIPRASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ziprasidone Hydrochloride
Dosage Form
CAPSULE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZIPRASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ziprasidone Hydrochloride
Dosage Form
CAPSULE
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZIPRASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ziprasidone Hydrochloride
Dosage Form
CAPSULE
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ZIPRASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OLMESARTAN MEDOXOMIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Raloxifene Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RALOXIFENE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-08-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atazanavir
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATAZANAVIR SULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atazanavir
Dosage Form
CAPSULE
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATAZANAVIR SULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atazanavir
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATAZANAVIR SULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Atazanavir
Dosage Form
CAPSULE
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ATAZANAVIR SULFATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2018-06-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Raloxifene-Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RALOXIFENE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tadalafil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TADALAFIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lacosamide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LACOSAMIDE
Product Type
BULK INGREDIENT
DEA Schedule
CV
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rabeprazole Sodium
Dosage Form
TABLET, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
RABEPRAZOLE SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-02-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ESOMEPRAZOLE SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Telmisartan
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TELMISARTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Palonosetron Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PALONOSETRON HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-09
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLMESARTAN MEDOXOMIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLMESARTAN MEDOXOMIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
OLMESARTAN MEDOXOMIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium Dihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ESOMEPRAZOLE MAGNESIUM DIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Valganciclovir Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VALGANCICLOVIR HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
75 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
150 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
225 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PREGABALIN
Dosage Form
CAPSULE
Strength
300 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PREGABALIN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CV
Start Marketing Date
2023-03-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fenofibrate
Dosage Form
TABLET, COATED
Strength
48 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FENOFIBRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-05-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fenofibrate
Dosage Form
TABLET, COATED
Strength
145 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FENOFIBRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-05-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 20 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
12.5; 40 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil and Hydrochlorothiazide
Dosage Form
TABLET, FILM COATED
Strength
25; 40 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2017-04-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM DIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-04-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium
Dosage Form
CAPSULE, DELAYED RELEASE
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESOMEPRAZOLE MAGNESIUM DIHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-04-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen Sodium
Dosage Form
TABLET, FILM COATED
Strength
220 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NAPROXEN SODIUM
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-03-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pregabalin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PREGABALIN
Product Type
BULK INGREDIENT
DEA Schedule
CV
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cefixime
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CEFIXIME
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Gatifloxacin Hemihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
GATIFLOXACIN HEMIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Celecoxib
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CELECOXIB
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Armodafinil
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ARMODAFINIL
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2023-11-03
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Bosentan Monohydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BOSENTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dutasteride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DUTASTERIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Entecavir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ENTECAVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cinacalcet Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CINACALCET HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Solifenacin Succinate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SOLIFENACIN SUCCINATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Zolmitriptan
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZOLMITRIPTAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Methenamine Hippurate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
METHENAMINE HIPPURATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Prasugrel Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PRASUGREL HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Saxagliptin Monohydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SAXAGLIPTIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pitavastatin Calcium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PITAVASTATIN CALCIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-05
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Montelukast Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MONTELUKAST SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLOZAPINE
Dosage Form
TABLET
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLOZAPINE
Dosage Form
TABLET
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLOZAPINE
Dosage Form
TABLET
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
CLOZAPINE
Dosage Form
TABLET
Strength
200 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CLOZAPINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tadalafil
Dosage Form
TABLET, FILM COATED
Strength
2.5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TADALAFIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-03-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tadalafil
Dosage Form
TABLET, FILM COATED
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TADALAFIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-03-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tadalafil
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TADALAFIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-03-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tadalafil
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
TADALAFIL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2019-03-26
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famotidine
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMOTIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-12-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Famotidine
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FAMOTIDINE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-12-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Darifenacin Hydrobromide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DARIFENACIN HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Isosulfan Blue
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ISOSULFAN BLUE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Voriconazole
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VORICONAZOLE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dalfampridine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DALFAMPRIDINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fondaparinux Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FONDAPARINUX SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sevelamer Carbonate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SEVELAMER CARBONATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dextromethorphan Hydrobromide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DEXTROMETHORPHAN HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
nitrofurantoin (monohydrate/macrocrystals)
Dosage Form
CAPSULE
Strength
25; 75 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
NITROFURANTOIN; NITROFURANTOIN MONOHYDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PARICALCITOL
Dosage Form
CAPSULE, LIQUID FILLED
Strength
1 ug/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PARICALCITOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-08-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PARICALCITOL
Dosage Form
CAPSULE, LIQUID FILLED
Strength
2 ug/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PARICALCITOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-08-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
PARICALCITOL
Dosage Form
CAPSULE, LIQUID FILLED
Strength
4 ug/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
PARICALCITOL
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2021-08-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Lurasidone HCl
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LURASIDONE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dabigatran Etexilate Mesylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DABIGATRAN ETEXILATE MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
LURASIDONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LURASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
LURASIDONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LURASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
LURASIDONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LURASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
LURASIDONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
80 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LURASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
LURASIDONE HYDROCHLORIDE
Dosage Form
TABLET
Strength
120 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
LURASIDONE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-03-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Naproxen
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
NAPROXEN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Dolutegravir Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DOLUTEGRAVIR SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Fexofenadine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
FEXOFENADINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-12-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ESZOPICLONE
Dosage Form
TABLET, FILM COATED
Strength
1 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESZOPICLONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2016-09-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ESZOPICLONE
Dosage Form
TABLET, FILM COATED
Strength
2 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESZOPICLONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2016-09-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
ESZOPICLONE
Dosage Form
TABLET, FILM COATED
Strength
3 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ESZOPICLONE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
CIV
Start Marketing Date
2016-09-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Linagliptin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LINAGLIPTIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-11
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rivaroxaban
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIVAROXABAN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-12
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Divalproex Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DIVALPROEX SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-08
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Telmisartan and Hydrochlorothiazide
Dosage Form
TABLET
Strength
12.5; 40 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; TELMISARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Telmisartan and Hydrochlorothiazide
Dosage Form
TABLET
Strength
12.5; 80 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; TELMISARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Telmisartan and Hydrochlorothiazide
Dosage Form
TABLET
Strength
25; 80 mg/1; mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
HYDROCHLOROTHIAZIDE; TELMISARTAN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-12-15
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Esomeprazole Magnesium Dihydrate Process II
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ESOMEPRAZOLE MAGNESIUM DIHYDRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ranolazine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RANOLAZINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-01-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rivastigmine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIVASTIGMINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2023-11-14
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rosuvastatin Calcium (Process II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ROSUVASTATIN CALCIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-10-07
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Viloxazine Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VILOXAZINE HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-10-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Brivaracetam
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BRIVARACETAM
Product Type
BULK INGREDIENT
DEA Schedule
CV
Start Marketing Date
2024-10-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Penicillin G Benzathine
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PENICILLIN G BENZATHINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-03-18
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Olmesartan Medoxomil (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
OLMESARTAN MEDOXOMIL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Perampanel Hemisesquihydrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PERAMPANEL HYDRATE (4:3)
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Prucalopride Succinate
Dosage Form
POWDER
Strength
1 kg/kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PRUCALOPRIDE SUCCINATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Rifaximin
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
RIFAXIMIN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2024-12-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
BACLOFEN
Dosage Form
TABLET
Strength
5 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BACLOFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-21
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Sitagliptin Phosphate Anhydrous (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SITAGLIPTIN PHOSPHATE ANHYDROUS
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Tamoxifen Citrate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
TAMOXIFEN CITRATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Belumosudil Mesylate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BELUMOSUDIL MESYLATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-01-22
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Clorazepate Dipotassium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CLORAZEPATE DIPOTASSIUM
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2025-02-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Cabotegravir
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CABOTEGRAVIR
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-02-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Auropap 90F (Acetaminophen Directly Compressible Granules)
Dosage Form
GRANULE
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ACETAMINOPHEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-08-02
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Calcium Carbonate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CALCIUM CARBONATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-03-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mirtazapine (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MIRTAZAPINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-03-01
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Enoxaparin Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ENOXAPARIN SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-03-25
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Divalproex Sodium (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DIVALPROEX SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-05-19
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
25 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SERTRALINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-20
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
50 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SERTRALINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-20
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Sertraline Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
100 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
SERTRALINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2025-11-20
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Benazepril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Benazepril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Benazepril Hydrochloride
Dosage Form
TABLET, FILM COATED
Strength
40 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
BENAZEPRIL HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
TABLET, FILM COATED
Strength
10 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-15
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
TABLET, FILM COATED
Strength
20 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-15
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Fluoxetine
Dosage Form
TABLET, FILM COATED
Strength
60 mg/1
Labeler
Aurobindo Pharma Limited
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
FLUOXETINE HYDROCHLORIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-15
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Vonoprazan Fumarate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VONOPRAZAN FUMARATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-10-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Methocarbamol
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
METHOCARBAMOL
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-10-16
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Mavacamten
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MAVACAMTEN
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-10-10
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Pitavastatin Calcium (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PITAVASTATIN CALCIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2025-11-21
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Montelukast Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MONTELUKAST SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-01-20
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Bupropion Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BUPROPION HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-01-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Suvorexant
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
SUVOREXANT
Product Type
BULK INGREDIENT
DEA Schedule
CIV
Start Marketing Date
2026-02-09
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Cabotegravir Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
CABOTEGRAVIR SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-02-05
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Emtricitabine (Process-IV)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
EMTRICITABINE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-02-26
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Valganciclovir Hydrochloride (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
VALGANCICLOVIR HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-03-18
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Desvenlafaxine Succinate (Process-II)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
DESVENLAFAXINE SUCCINATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-03-25
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Magnesium Hydroxide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
MAGNESIUM HYDROXIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-03-31
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Avibactam Sodium (Non-Sterile)
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
AVIBACTAM SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-06-17
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Benzgalantamine Gluconate
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BENZGALANTAMINE GLUCONATE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-06-16
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Bupropion Hydrobromide
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
BUPROPION HYDROBROMIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-06-11
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Lenacapavir Sodium
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
LENACAPAVIR SODIUM
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-06-15
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Pivmecillinam Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
PIVMECILLINAM HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-06-11
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Zavegepant Hydrochloride
Dosage Form
POWDER
Strength
50 kg/50kg
Labeler
Aurobindo Pharma Limited
Marketing Category
BULK INGREDIENT
Substance
ZAVEGEPANT HYDROCHLORIDE
Product Type
BULK INGREDIENT
DEA Schedule
Start Marketing Date
2026-06-15
End Marketing Date
-
Listing Record Certified Through
2027-12-31
NDC Type Breakdown
869 total- Drug for Further Processing
- Bulk Ingredient
Official Source
NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).
Visit FDA NDC DirectoryNDC Record Details Preview
Explore important National Drug Code information available in the records above.
NDC
59651-001
Nonproprietary Name
Omeprazole
Labeler
Aurobindo Pharma Limited
Dosage Form
CAPSULE, DELAYED RELEASE
FDA NDC Data
National Drug Code information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized NDC records
Create a New Buying Request
Fields marked with * are mandatory.